AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first ...

AbbVie has received US FDA approval for Emblaveo to be used in conjunction with metronidazole for individuals with cIAI.

AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, ...

Emblaveo is a fixed-dose IV treatment that combines aztreonam, a monobactam antibiotic, and avibactam, a β-lactamase inhibitor.

The drug is cleared to treat complicated intra-abdominal infections, including those caused by tough-to-control, ...

Emblaveo marks the first and only fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic to be ...

AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options: North Chicago, Illinois Monday, Febr ...

The four selected RCTs compared antiseptics to metronidazole or clindamycin. In two studies control treatment consisted of a single oral dose of 2 g metronidazole, in one study of a 7-day regime ...

AbbVie has announced that the US Food and Drug Administration (FDA) has approved its Pfizer-partnered Emblaveo ...

Combination birth control pills, or the pill for short, are oral contraceptives that prevent pregnancy. If you’re considering your birth control options, the pill is one of the most common and ...

The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...

Choosing the right wellness products can contribute to these efforts, and a reliable pill organizer is an essential one for those taking medications, vitamins or supplements. With seemingly endles ...